Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the treatment of schizophrenia in adults
Fri, 28/07/2023 - 12:01
1 minRisperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the treatment of schizophrenia in adults
img_7360.jpg
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®